Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients

Status:
Completed

Trial end date:
2015-08-31

Target enrollment:

Participant gender:

The purpose of this study is to assess safety, PK/PD and Urate Lowering Effect of URC102 in gout patients with hyperuricemia

Phase 2

JW Pharmaceutical